Recombinant interferon alfa-2C versus polychemotherapy (VMCP) for treatment of multiple myeloma: a prospective randomized trial

Heinz Ludwig, R. Flener, Werner Scheithauer et al.|European Journal of Cancer and Clinical Oncology|1986

Cited by 44